Using SPECT-CT allows clinicians to identify some causes of low back pain.
Management of low back pain is frequently changed when clinicians use SPECT-CT to identify the causes of low back pain, according to a study to be presented in September at the Royal College of Radiologists Annual Scientific Meeting, which will be held in London, U.K.
In this retrospective study, researchers evaluated whether using SPECT-CT would change the management of patients who present with lower back pain. They evaluated 29 SPECT-CT scans, reviewing clinical history and previous surgical and radiological management, before and after the scan.
Of the patients whose pain originated from joints, none underwent surgery. Of the seven who had discogenic pain, one patient had L5 pars defects and all seven were either advised to have or did have surgery.
Three of the 29 cases were used to rule out infection; six cases showed increased activity in facet joints on the opposite side of symptoms, and five cases showed no increased activity. There were also two patients who were advised to have surgery because of non-union identified on the CT that did not show increased activity
The researchers concluded that SPECT-CT was found to change management in 76 percent of the patients who had lower back pain. They were able to identify discogenic and joint pain, and to rule out infection. However, the imaging was “not useful for identifying the source of pain in non-union, and in half of the cases of facet joint pain; increased activity was seen on the opposite side of symptoms,” they wrote.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.